Central Chapter (Non-CE)

Thursday, October 25, 2018

Event date: 11/27/2018 6:30 PM - 8:00 PM Export event

A Paradigm Shift for Extended VTE Thromboprophylaxis in Hospitalized, Nonsurgical, Acutely Ill Patients (Non-CE Presentation/Networking Event)


Jeff Nemeth, BSP, Pharm.D., MPA, CACP

Director of Pharmacy

Engelwood Hospital and Medical Center

Engelwood, NJ


Tuesday, November 27, 2018


Steakhouse 85

85 Church Street

New Brunswick, NJ 08901

(732) 247-8585


6:30 PM


1. Review the burden of VTE in nonsurgical, acutely ill patients

2. Provide an overview of the unmet need for in-hospital and extended VTE thromboprophylaxis

3. Review the APEX clinical trial data

4. Provide an overview of Bevyxxa® (betrixaban) indication, safety information, dosing and

    appropriate patient types


This program is sponsored by Portola Pharmaceuticals.

In accordance with PhRMA Code on Interactions with Health Care Professionals, attendance at this educational program is limited to health care professionals.  Attendance by guests or spouses is not appropriate and cannot be accommodated.

This is not an independent educational program, and no CME credits will be provided.



About the Central Chapter

The Central Chapter Membership includes members who either live or work in the counties of Hunterdon, Mercer, Middlesex, Monmouth, Ocean, and Somerset.

President: Maria Cardinale
President-Elect: Toral Patel
Secretary: Lawrence (Larry) Kaiserman
Treasurer: Alex Kardos

Central Chapter News

Central Chapter

Beta Lactam Antibiotics and Skin Testing

Saint Peter's University Medical Center

New Brunswick, NJ 08901

Registration: 6:00 PM

Please plan to attend.

The Role of the Pharmacist in the Management of Chronic Obstructive Pulmonary Disease

NJSHP Central Chapter Meeting - 10/24/18

This program will review the role of the pharmacist in the management of COPD. Please join us as Dr. Fahim walks us through the pathophysiology of Chronic Obstructive Pulmonary Disorder (COPD), summarizes current treatment guidelines and identify emerging drug therapies for COPD, and discusses the pharmacist’s role in the management of COPD.